A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax

被引:69
作者
Kagawa, S
Pearson, SA
Ji, L
Xu, K
McDonnell, TJ
Swisher, SG
Roth, JA
Fang, B
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Sect Thorac Mol Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA
关键词
gene therapy; apoptosis; bax gene; cell death;
D O I
10.1038/sj.gt.3301048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The bax gene plays a critical role in signaling apoptosis and expression through gene transfer may be valuable in the treatment of a variety of apoptosis-related diseases such as cancer. However, constructing an adenoviral vector expressing a bax gene driven by a constitutive promoter has been difficult, presumably because of the gene's high proapoptotic activity. Here we report a system that induces the expression of the bax gene safely by adenovirus-mediated gene cotransfer. Briefly, the system involves an adenoviral vector containing a human bax cDNA driven by a synthetic promoter consisting of five GAL4-binding sites and a TATA box (GT). This vector expresses a minimal background level of bax protein in cultured mammalian cells thus preventing apoptosis of packaging cells. However, expression of the bax gene can be induced substantially in vitro and in vivo by transferring it into target cells along with an adenoviral vector expressing the transactivator, fusion protein GAL4/VP16. Extensive apoptosis was observed after induction of the bax gene both in cultured human lung carcinoma cells and in the livers of Balb/c mice. Our results suggest that this GAL4 gene regulatory system provides an alternative approach to constructing viral vectors that express potentially toxic genes.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 15 条
[1]   MAPPING OF THE HUMAN BAX GENE TO CHROMOSOME 19Q13.3-Q13.4 AND ISOLATION OF A NOVEL ALTERNATIVELY SPLICED TRANSCRIPT, BAX-DELTA [J].
APTE, SS ;
MATTEI, MG ;
OLSEN, BR .
GENOMICS, 1995, 26 (03) :592-594
[2]   Gene transfer of Fas ligand induces tumor regression in vivo [J].
Arai, H ;
Gordon, D ;
Nabel, EG ;
Nabel, GJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13862-13867
[3]   Antitumor activity of bax and p53 naked gene transfer in lung cancer:: In vitro and in vivo analysis [J].
Coll, JL ;
Negoescu, A ;
Louis, N ;
Sachs, L ;
Tenaud, C ;
Girardot, V ;
Demeinex, B ;
Brambilla, E ;
Brambilla, C ;
Favrot, M .
HUMAN GENE THERAPY, 1998, 9 (14) :2063-2074
[4]   Evaluation of GAL4/TATA in vivo -: Induction of transgene expression by adenovirally mediated gene codelivery [J].
Fang, BL ;
Ji, L ;
Bouvet, M ;
Roth, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) :4972-4975
[5]   Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo [J].
Fueyo, J ;
Gomez-Manzano, C ;
Yung, WKA ;
Liu, TJ ;
Alemany, R ;
McDonnell, TJ ;
Shi, X ;
Rao, JS ;
Levin, VA ;
Kyritsis, AP .
NATURE MEDICINE, 1998, 4 (06) :685-690
[6]   Adenoviral vectors for gene transfer [J].
Kovesdi, I ;
Brough, DE ;
Bruder, JT ;
Wickham, TJ .
CURRENT OPINION IN BIOTECHNOLOGY, 1997, 8 (05) :583-589
[7]   Fast induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate E1-deleted adenoviral vectors [J].
Larregina, AT ;
Morelli, AE ;
Dewey, RA ;
Castro, MG ;
Fontana, A ;
Lowenstein, PR .
GENE THERAPY, 1998, 5 (04) :563-568
[8]   The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors [J].
Lieber, A ;
He, CY ;
Meuse, L ;
Schowalter, D ;
Kirillova, I ;
Winther, B ;
Kay, MA .
JOURNAL OF VIROLOGY, 1997, 71 (11) :8798-8807
[9]   Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system [J].
Okuyama, T ;
Fujino, M ;
Li, XK ;
Funeshima, N ;
Kosuga, M ;
Saito, I ;
Suzuki, S ;
Yamada, M .
GENE THERAPY, 1998, 5 (08) :1047-1053
[10]  
OLIVAI ZN, 1993, CELL, V74, P609